Healthcare & Life Sciences
LabGenius Therapeutics
United Kingdomlabgeniustx.com/
LabGenius Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About LabGenius Therapeutics
LabGenius Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
LabGenius Therapeutics develops therapeutic antibodies using an automated platform called EVA that applies machine learning to discover and optimize complex antibody molecules, focusing on selectivity-enhanced antibodies for treating solid tumors.
Explore LabGenius Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.